These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12224374)

  • 21. Pharmacotherapeutic blood pressure management in a chronic kidney disease patient.
    Salinitri F; Berlie H; Desai N
    AACN Adv Crit Care; 2009; 20(3):205-13; quiz 214-5. PubMed ID: 19638739
    [No Abstract]   [Full Text] [Related]  

  • 22. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
    Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peripheral artery disease: a cause of refractory hypertension after renal transplantation.
    Dourado R; Gonçalves Pde A; Almeida M; Weigert A; Bruges M; Gaspar A; Negrão AP; Machado D; Clemente B; Teles R; Machado FP; Silva A
    Rev Port Cardiol; 2008 Mar; 27(3):353-7. PubMed ID: 18551921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner.
    Roberts ME; Epstein BJ
    J Cardiovasc Nurs; 2009; 24(5):380-9. PubMed ID: 19707098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacologic treatment of hypertension in patients with chronic kidney disease.
    Talreja H; Ruzicka M; McCormick BB
    Am J Cardiovasc Drugs; 2013 Jun; 13(3):177-88. PubMed ID: 23553321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of hypertension in the child with chronic renal disease.
    Feld LG; Lieberman E; Mendoza SA; Springate JE
    J Pediatr; 1996 Aug; 129(2):s18-26. PubMed ID: 8765645
    [No Abstract]   [Full Text] [Related]  

  • 28. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of hypertension in patients with chronic kidney disease and diabetes mellitus.
    Palmer BF
    Am J Med; 2008 Aug; 121(8 Suppl):S16-22. PubMed ID: 18638614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Which optimal antihypertensive bitherapy for kidney patients?].
    Bonne JF; Shahapuni I; Mailliez S; Oprisiu R; Temmar M; Choukroun G; Massy ZA; Fournier A
    Nephrol Ther; 2007 Jun; 3(3):79-88. PubMed ID: 17540309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Resistant hypertension and paradox effect in patient with hemodialysis treatment].
    Caglioti A; Bova F; Tozzo C; Fuiano G
    G Ital Nefrol; 2006; 23(2):235-9. PubMed ID: 16710829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathologic basis and treatment considerations in chronic kidney disease-related hypertension.
    Sica D; Carl D
    Semin Nephrol; 2005 Jul; 25(4):246-51. PubMed ID: 16202697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment and management of hypertension in patients with type 2 diabetes.
    Thomas MC; Atkins R
    Intern Med J; 2009 Mar; 39(3):143-9. PubMed ID: 18771428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug therapy for hypertension in hemodialysis patients.
    Hörl MP; Hörl WH
    Semin Dial; 2004; 17(4):288-94. PubMed ID: 15250920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [May medical therapy of arterial hypertension by used in patients with renal failure?].
    Richet G; Ducrot H; Hamburger J; Legrain M; Maxwell M; Péquignot MH
    Presse Med (1893); 1968 Nov; 76(44):2103-6. PubMed ID: 5701039
    [No Abstract]   [Full Text] [Related]  

  • 37. Influence of hypertension on the rate of progression of chronic renal failure.
    Vetter K; Lindenau K; Krupki F; Sperscnheider H; Fröhling PT
    Scand J Urol Nephrol Suppl; 1988; 108():21-3. PubMed ID: 3163826
    [No Abstract]   [Full Text] [Related]  

  • 38. Metabolic syndrome: treatment of hypertensive patients.
    Israili ZH; Lyoussi B; Hernández-Hernández R; Velasco M
    Am J Ther; 2007; 14(4):386-402. PubMed ID: 17667215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antihypertensive therapy in early stages of chronic kidney disease. Second and third stages of chronic kidney disease].
    Gorostidi M; Marín R;
    Nefrologia; 2004; 24 Suppl(6):91-100, 187-235. PubMed ID: 15696900
    [No Abstract]   [Full Text] [Related]  

  • 40. The impact of losartan on the lifetime incidence of ESRD and costs in Mexico.
    Arredondo A; Burke TA; Carides GW; Lemus E; Querol J
    Rev Invest Clin; 2005; 57(3):399-405. PubMed ID: 16187699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.